KSPHF Stock Price, Chart, Stats & News
Kissei Pharmaceutical Co., Ltd. (KSPHF) is a dividend-paying stock with a current dividend yield of 8.00% as of Oct 20, 2026. It pays $1.96 per share over the trailing twelve months. Its dividend has grown at a 40.54% 5-year compound annual rate.
Dividend safety
KSPHF pays out about 91% of earnings, leaving little safety margin.
KSPHF chart
About
Kissei Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in Japan. The company offers Calogra tablets, for the treatment of ulcerative colitis; Tabneos capsules for the treatment of microscopic polyangiitis and granulomatous polyangiitis; Minirin Melt OD tablets; Corsuba Intravenous Dialysis Syringe for the treatment of chronic idiopathic thrombocytopenic purpura; Beova tablets for the treatment of overactive bladder treatment; and Darbepoetin Alfa BS injection JCR for the treatment of renal anemia. Its products in pipeline include CG0070, which is in Phase III clinical trial to treat non-muscle-invasive bladder cancer; Linzagolix, which is in Phase III clinical trial for the treatment of uterine fibroids and endometriosis; KDT-3594, which is in Phase II clinical trial to treat Parkinson's disease; KSP-0243 that is in Phase II clinical trial to treat Ulcerative colitis; and Difelikefalin, which is in Phase III clinical trial to treat uremic pruritus in dialysis patients.
Related lists
Similar securities
Based on sector and market capitalization
